Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
JPMorgan Chase
JPM
|
$1.79B |
| 2 |
PNC Financial Services
PNC
|
$1.5B |
| 3 |
Vale
VALE
|
$1.41B |
| 4 |
Chevron
CVX
|
$1.32B |
| 5 |
Citigroup
C
|
$1.25B |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$1.66B |
| 2 |
Corpay
CPAY
|
$1.64B |
| 3 |
Exxon Mobil
XOM
|
$1.14B |
| 4 |
Constellation Brands
STZ
|
$1.08B |
| 5 |
Dominion Energy
D
|
$841M |
Sector Composition
| 1 | Technology | 19.84% |
| 2 | Healthcare | 16.81% |
| 3 | Communication Services | 14.24% |
| 4 | Consumer Discretionary | 13.11% |
| 5 | Financials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
SBA Communications
SBAC
$22B
| $1.31B | 0.34% | 4,631,987 +273,186 | +6% | +$77.1M |
|
77
Hasbro
HAS
$11.4B
| $1.26B | 0.33% | 13,452,450 +801,554 | +6% | +$75M |
|
78
Teva Pharmaceuticals
TEVA
$21.1B
| $1.26B | 0.33% | 130,140,247 +32,778 | +0% | +$316K |
|
79
McDonald's
MCD
$224B
| $1.25B | 0.32% | 5,834,315 +2,443 | +0% | +$524K |
|
80
Dow Inc
DOW
$17.5B
| $1.2B | 0.31% | 21,600,298 +70,547 | +0.3% | +$3.92M |
|
81
Union Pacific
UNP
$133B
| $1.18B | 0.31% | 5,690,336 -270,301 | -5% | -$56.3M |
|
82
Equinix
EQIX
$76.9B
| $1.17B | 0.3% | 1,635,495 +199,147 | +14% | +$142M |
|
83
Verizon
VZ
$186B
| $1.16B | 0.3% | 19,738,093 +1,189,312 | +6% | +$69.9M |
|
84
Ryanair
RYAAY
$33.7B
| $1.15B | 0.3% | 10,500,000 +1,648,440 | +19% | +$181M |
|
85
Medtronic
MDT
$119B
| $1.15B | 0.3% | 9,782,151 +2,559,030 | +35% | +$300M |
|
86
Humana
HUM
$36.5B
| $1.12B | 0.29% | 2,730,757 -812,789 | -23% | -$333M |
|
87
Costco
COST
$418B
| $1.1B | 0.29% | 2,919,155 -894,442 | -23% | -$337M |
|
88
Duke Energy
DUK
$95.3B
| $1.08B | 0.28% | 11,847,673 +4,808,466 | +68% | +$440M |
|
89
Deutsche Bank
DB
$67.7B
| $1.08B | 0.28% | 98,823,423 +21,500,116 | +28% | +$234M |
|
90
American Tower
AMT
$95.5B
| $1.07B | 0.28% | 4,744,800 +167,122 | +4% | +$37.5M |
|
91
S&P Global
SPGI
$167B
| $1.05B | 0.27% | 3,179,438 +104,568 | +3% | +$34.4M |
|
92
HDFC Bank
HDB
$182B
| $1.04B | 0.27% | 14,407,268 +15,753 | +0.1% | +$1.14M |
|
93
NextEra Energy, Inc.
NEE
$148B
| $1.04B | 0.27% | 13,468,550 +9,783,549 | +265% | +$755M |
|
94
Ultragenyx Pharmaceutical
RARE
$2.89B
| $1.01B | 0.26% | 7,261,901 +477,833 | +7% | +$66.1M |
|
95
Caterpillar
CAT
$196B
| $974M | 0.25% | 5,350,148 +437,643 | +9% | +$79.7M |
|
96
Lamb Weston
LW
$8.02B
| $952M | 0.25% | 12,094,938 -4,479,356 | -27% | -$353M |
|
97
Petrobras Class A
PBR.A
$73.9B
| $943M | 0.24% | 85,230,908 -8,058,359 | -9% | -$89.1M |
|
98
Diamondback Energy
FANG
$43.1B
| $936M | 0.24% | 19,337,005 +339,190 | +2% | +$16.4M |
|
99
Edwards Lifesciences
EW
$47.8B
| $936M | 0.24% | 10,258,471 -258,468 | -2% | -$23.6M |
|
100
Procter & Gamble
PG
$368B
| $914M | 0.24% | 6,572,075 -2,425,220 | -27% | -$337M |
|